Amedisys to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 06 2017 - 11:00AM
Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health
and hospice care companies, today announced that Paul B. Kusserow,
President and Chief Executive Officer will present at the 35th
Annual J.P. Morgan Healthcare Conference in San Francisco, CA on
Wednesday, January 11, 2017.
The presentation will begin at 12:00 p.m. Pacific Time. To
access a live webcast of the Amedisys presentation, please log on
through our website at http://investors.amedisys.com.
About Amedisys
Amedisys, Inc. is a leading healthcare at home Company
delivering personalized home health, hospice and personal care.
Amedisys is focused on delivering the care that is best for our
patients, whether that is home-based personal care; recovery and
rehabilitation after an operation or injury; care focused on
empowering them to manage a chronic disease; or hospice care at the
end of life. More than 2,200 hospitals and 61,900 physicians
nationwide have chosen Amedisys as a partner in post-acute care.
Founded in 1982, headquartered in Baton Rouge, LA with an executive
office in Nashville, TN, Amedisys is a publicly held company. With
more than 16,000 employees, in 421 care centers in 34 states,
Amedisys is dedicated to delivering the highest quality of care to
the doorsteps of more than 340,000 patients in need every year. For
more information about the Company, please visit:
www.amedisys.com.
Our company website address is http://www.amedisys.com. We
use our website as a channel of distribution for important company
information. Important information, including press releases,
analyst presentations and financial information regarding the
Company is routinely posted on and accessible on the "Investor
Relations" subpage of our website, which is accessible by clicking
on the tab labeled "Investors" on our website home page. We will
also use our website to expedite public access to time-critical
information regarding the Company in advance of or in lieu of
distributing a press release or a filing with the Securities and
Exchange Commission ("SEC") disclosing the same information. In
addition, we make available on the Investor Relations subpage of
our website (under the link "SEC filings") free of charge our
annual reports on Form 10-K, quarterly reports on Form 10-Q,
current reports on Form 8-K, ownership reports on Forms 3, 4 and 5
and any amendments to those reports as soon as practicable after we
electronically file such reports with the SEC. Further, copies of
our Certificate of Incorporation and Bylaws, our Code of Ethical
Business Conduct and the charters for the Audit, Compensation and
Nominating and Governance Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
Contact:
Amedisys, Inc.
David Castille
Managing Director, Finance
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024